160
Participants
Start Date
January 31, 2007
Primary Completion Date
January 31, 2009
Study Completion Date
February 28, 2009
risedronate
risedronate 35mg tablet, weekly for 12 months
risedronate
35mg weekly
Control
risedronate-matched placebo weekly
Southern Interior Medical Research Corporation, Kelowna
Dr. Cal Andreou, Surrey
Dr. Allan Patrick, Fredericton
The Male/Female Health and Research Centre, Barrie
Dr. Stanley Flax, Brampton
Brantford Urology Research, Medical Arts Building, Brantford
G. Kenneth Jansz Medicine Professional Corporation, Burlington
Urology Research Centre, Burlington
Northern Urology Centre, Greater Sudbury
Guelph Urology Associates, Guelph
Credit Valley Medical Arts Centre, Mississauga
Mor Urology Inc., Bayview Business Centre, Newmarket
The Male and Female Health Centre, Oakville
Orillia Urology Associates, Orillia
Urotec, Oshawa
Dr. Todd Webster, Owen Sound
Kawartha Urology Associates, Peterborough
Dr. Allan Abramovitch, Scarborough Village
The Male Health Centre, Toronto
Dr. Roger J. Buckley, Willowdale
Urology South Shore Research, Greenfield Park
Lead Sponsor
Collaborators (1)
Sanofi
INDUSTRY
CMX Research
OTHER